CHARLES KANDALAFT: Open Payments
NPI 1467499798 · VALHALLA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 38 payments from 6 companies in 2025. Trend: 2023 $752 · 2024 $1,023 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $322 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $225 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $135 |
| Lundbeck LLC | 5 | $129 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $28 |
Products named: VRAYLAR, TRINTELLIX, REXULTI, CAPLYTA, Auvelity.
Industry payments across NY — which companies pay providers there.
